The emergence of immune checkpoint inhibitors has dramatically changed the therapeutic landscape for patients with advanced melanoma. However, relatively low response rates and a high incidence of sev
This population-based retrospective cohort study uses data from the Regional Cancer Registry (RTV) of the Veneto Region (northeast Italy) to evaluate the impact of different patterns of comorbidities
To analyse whether the activation of TGF-ß signalling (recombinant hTGF-ß, 5 ng/mL; PeproTech) is able to invoke a full phenotype- switch, we performed RNA sequencing of melanoma cultures from two ind
14 patients were first diagnosed with IgAN according to the renal biopsies, and 15 healthy people were recruited at the first affiliated Hospital of Jinan University.
